Back
Evolution AB Vs. Aligos Therapeutics Industry Stock Comparison
Sell
12
EVVTY
Evolution AB
Last Price:
$75.15
Seasonality Move:
14.6%
Buy
62
ALGS
Aligos Therapeutics
Last Price:
$33.58
Seasonality Move:
-18.25%
Sell
12
Evolution AB (EVVTY)
is a Sell
Is Evolution AB a Buy, Sell or Hold?
-
The current Evolution AB [EVVTY] share price is $76.00. The Score for EVVTY is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
-
EVVTY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
62
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $38.39. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EVVTY Stock Price Chart
What is Evolution AB's stock price today?
-
The Evolution AB share price today is $76.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVVTY is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $38.39The current trend is moderately bearish and ALGS is experiencing slight selling pressure.
EVVTY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.69 | Sell |
Relative Strength Index (14 RSI): | 34.17 | Sell |
Chaikin Money Flow: | 13427 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (77.26 - 86.66) | Sell |
Bollinger Bands (100): | (84.56 - 99.82) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.47 | Buy |
Relative Strength Index (14 RSI): | 56.78 | Buy |
Chaikin Money Flow: | -32589 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.39 - 41.59) | Buy |
Bollinger Bands (100): | (6.9 - 29.68) | Buy |
EVVTY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 78.06 | Sell |
20-day SMA: | 80.49 | Sell |
50-day SMA: | 86.56 | Sell |
200-day SMA: | 100.43 | Sell |
8-day EMA: | 78.29 | Sell |
20-day EMA: | 80.44 | Sell |
50-day EMA: | 85.27 | Sell |
200-day EMA: | 97.46 | Sell |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.2 | Sell |
20-day SMA: | 38.15 | Buy |
50-day SMA: | 25.97 | Buy |
200-day SMA: | 17.23 | Buy |
8-day EMA: | 40.71 | Sell |
20-day EMA: | 37.37 | Buy |
50-day EMA: | 29.03 | Buy |
200-day EMA: | 19.88 | Buy |
Evolution AB Earnings Growth & EVVTY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
Evolution AB Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |